ArticleHuman genomics2025
Expanding the phenotype associated with biallelic SCNM1 variants.
Article in Human genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundOral-facial-digital (OFD) syndrome comprises a number of genetically and clinically heterogeneous ciliopathies characterized by distinctive craniofacial, oral cavity and extremities abnormalities. Recently, SCNM1, encoding a protein component of the minor spliceosome, was associated with OFD syndrome. Until now, only three families had been described with pathogenic variants in this gene.
resultsUsing exome sequencing, we identified biallelic variants in SCNM1 in five additional patients diagnosed with OFD syndrome from four unrelated families. Clinical evaluation of these patients revealed novel features linked to SCNM1 including neurodevelopmental disorders, oculomotor apraxia and skeletal abnormalities. The pathogenicity of a missense variant affecting the C2H2 zinc finger domain of SCNM1, p.(His68Arg), was verified in fibroblasts from a patient with this variant in the homozygous state. These cells exhibited comparable defects to those previously reported in cells lacking SCNM1, including diminished expression of several U12-intron containing genes such as TMEM107 and CIBAR1, two ciliary genes previously associated with OFD syndrome and postaxial polydactyly, respectively, and abnormal primary cilia. In addition, the mutant version of SCNM1 harboring the p.(His68Arg) change was unable to rescue the phenotype of SCNM1-deficient cells.
conclusionsThis work expands the molecular and clinical landscape of the SCNM1-related condition and shows that pathogenic variants in this gene cause a complex phenotype overlapping with OFD types II and VI. Our data improves understanding of the ciliopathy linked to SCNM1, which is of paramount importance in terms of genetic counselling, particularly with regard to the risks associated with neurodevelopmental disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.